Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 387

1.

Tools for the Screening of Colorectal Cancer.

Lichtenstein GR.

Gastroenterol Hepatol (N Y). 2019 Aug;15(8):403. No abstract available.

2.

Nonalcoholic Fatty Liver Disease and Pregnancy.

Lichtenstein GR.

Gastroenterol Hepatol (N Y). 2019 Apr;15(4):180. No abstract available.

3.

Spotlight on Endoscopy.

Lichtenstein GR.

Gastroenterol Hepatol (N Y). 2019 Jul;15(7):351. No abstract available.

4.

De-Escalation of Therapy for Inflammatory Bowel Disease.

Lichtenstein GR.

Gastroenterol Hepatol (N Y). 2019 Jun;15(6):292. No abstract available.

5.

Eating Disorders and Disordered Eating Habits in Patients With Irritable Bowel Syndrome.

Lichtenstein GR.

Gastroenterol Hepatol (N Y). 2019 May;15(5):239. No abstract available.

6.

Postoperative Crohn's disease management: still learning and evolving.

Schneider Y, Lichtenstein GR.

Gastrointest Endosc. 2019 Aug;90(2):276-277. doi: 10.1016/j.gie.2019.04.208. No abstract available.

PMID:
31327339
7.

Lifetime Economic Burden of Crohn's Disease and Ulcerative Colitis by Age at Diagnosis.

Lichtenstein GR, Shahabi A, Seabury SA, Lakdawalla DN, Espinosa OD, Green S, Brauer M, Baldassano RN.

Clin Gastroenterol Hepatol. 2019 Jul 18. pii: S1542-3565(19)30765-7. doi: 10.1016/j.cgh.2019.07.022. [Epub ahead of print]

PMID:
31326606
8.

Editorial: mesalazine and mucosal microbiome in quiescent ulcerative colitis-what can we learn?

Buchner AM, Lichtenstein GR.

Aliment Pharmacol Ther. 2019 Jun;49(12):1531. doi: 10.1111/apt.15281. No abstract available.

PMID:
31134651
9.

Diet and Inflammatory Bowel Disease.

Lichtenstein GR.

Gastroenterol Hepatol (N Y). 2019 Mar;15(3):127. No abstract available.

10.

Hospitalization Outcomes for Inflammatory Bowel Disease in Teaching vs Nonteaching Hospitals.

Dalal RS, Vajravelu RK, Lewis JD, Lichtenstein GR.

Inflamm Bowel Dis. 2019 Apr 30. pii: izz089. doi: 10.1093/ibd/izz089. [Epub ahead of print]

PMID:
31039244
11.

Going Third Class: Treatment of Steroid-Dependent Ulcerative Colitis.

Lee H, Schneider Y, Lichtenstein GR.

Dig Dis Sci. 2019 May;64(5):1138-1141. doi: 10.1007/s10620-019-05610-w. No abstract available.

PMID:
31016561
12.

Strategies for Overcoming Barriers to Adopting Biosimilars and Achieving Goals of the Biologics Price Competition and Innovation Act: A Survey of Managed Care and Specialty Pharmacy Professionals.

Greene L, Singh RM, Carden MJ, Pardo CO, Lichtenstein GR.

J Manag Care Spec Pharm. 2019 Aug;25(8):904-912. doi: 10.18553/jmcp.2019.18412. Epub 2019 Apr 22.

13.

Response to Chapman and Jones.

Lichtenstein GR, Loftus EV, Isaacs KL, Regueiro MD, Sands BE.

Am J Gastroenterol. 2019 May;114(5):828. doi: 10.14309/ajg.0000000000000217. No abstract available.

PMID:
30985301
14.

Response to Ribaldone.

Lichtenstein GR, Loftus EV, Isaacs KL, Regueiro MD, Sands BE.

Am J Gastroenterol. 2019 May;114(5):826-827. doi: 10.14309/ajg.0000000000000216. No abstract available.

PMID:
30985300
15.

Food and Irritable Bowel Syndrome.

Lichtenstein GR.

Gastroenterol Hepatol (N Y). 2019 Jan;15(1):7. No abstract available.

16.

Identification and characterization of metabolite quantitative trait loci in tomato leaves and comparison with those reported for fruits and seeds.

Nunes-Nesi A, Alseekh S, de Oliveira Silva FM, Omranian N, Lichtenstein G, Mirnezhad M, González RRR, Sabio Y Garcia J, Conte M, Leiss KA, Klinkhamer PGL, Nikoloski Z, Carrari F, Fernie AR.

Metabolomics. 2019 Mar 15;15(4):46. doi: 10.1007/s11306-019-1503-8.

17.

Dietary Treatment of Eosinophilic Esophagitis.

Lichtenstein GR.

Gastroenterol Hepatol (N Y). 2018 Dec;14(12):683. No abstract available.

18.

J-Pouch-Related Complications.

Lichtenstein GR.

Gastroenterol Hepatol (N Y). 2018 Oct;14(10):555. No abstract available.

19.

A User-Friendly Prediction Tool to Identify Colectomy Risk in Patients With Ulcerative Colitis.

Dalal RS, Osterman MT, Buchner AM, Praestgaard A, Lewis JD, Lichtenstein GR.

Inflamm Bowel Dis. 2019 Aug 20;25(9):1550-1558. doi: 10.1093/ibd/izz014.

PMID:
30753443
20.

Response to Chamberlin and Borody.

Lichtenstein GR, Loftus EV Jr, Isaacs KL, Regueiro MD, Sands BE.

Am J Gastroenterol. 2019 Jan;114(1):171-174. doi: 10.14309/ajg.0000000000000077. No abstract available.

PMID:
30633034
21.

Management of Patients After Being Cured of Hepatitis C Virus Infection.

Lichtenstein GR.

Gastroenterol Hepatol (N Y). 2018 Nov;14(11):615. No abstract available.

22.

Systematic review: efficacy and safety of switching patients between reference and biosimilar infliximab.

Feagan BG, Lam G, Ma C, Lichtenstein GR.

Aliment Pharmacol Ther. 2019 Jan;49(1):31-40. doi: 10.1111/apt.14997. Epub 2018 Nov 8. Review.

23.

Mobile Applications for Inflammatory Bowel Disease Patients.

Lichtenstein GR.

Gastroenterol Hepatol (N Y). 2018 Sep;14(9):503. No abstract available.

24.

Highlights From the New ACG Guideline on Crohn's Disease Management.

Lichtenstein GR.

Gastroenterol Hepatol (N Y). 2018 Aug;14(8):482-484. No abstract available.

25.

New ACG Guideline for the Management of Crohn's Disease.

Lichtenstein GR.

Gastroenterol Hepatol (N Y). 2018 Aug;14(8):451. No abstract available.

26.

Evolving Considerations for Thiopurine Therapy for Inflammatory Bowel Diseases-A Clinical Practice Update: Commentary.

Hanauer SB, Sandborn WJ, Lichtenstein GR.

Gastroenterology. 2019 Jan;156(1):36-42. doi: 10.1053/j.gastro.2018.08.043. Epub 2018 Sep 7. Review.

PMID:
30195449
27.

Brain-Gut Therapies and Irritable Bowel Syndrome.

Lichtenstein GR.

Gastroenterol Hepatol (N Y). 2018 Jul;14(7):399. No abstract available.

28.

Traveling With Inflammatory Bowel Disease.

Lichtenstein GR.

Gastroenterol Hepatol (N Y). 2018 Jun;14(6):331. No abstract available.

29.

Improved Hemoglobin Response with Ferric Carboxymaltose in Patients with Gastrointestinal-Related Iron-Deficiency Anemia Versus Oral Iron.

Lichtenstein GR, Onken JE.

Dig Dis Sci. 2018 Nov;63(11):3009-3019. doi: 10.1007/s10620-018-5204-3. Epub 2018 Jul 28.

30.

Pregnancy Outcomes Reported During the 13-Year TREAT Registry: A Descriptive Report.

Lichtenstein GR, Feagan BG, Mahadevan U, Salzberg BA, Langholff W, Morgan JG, Safdi M, Nissinen R, Taillard F, Sandborn WJ, Cohen RD.

Am J Gastroenterol. 2018 Nov;113(11):1678-1688. doi: 10.1038/s41395-018-0202-9. Epub 2018 Jul 19.

PMID:
30022113
31.

Chronic Kidney Disease and Hepatitis C Virus Treatment.

Lichtenstein GR.

Gastroenterol Hepatol (N Y). 2018 May;14(5):263. No abstract available.

32.

Mimics of Inflammatory Bowel Disease.

Shivashankar R, Lichtenstein GR.

Inflamm Bowel Dis. 2018 Oct 12;24(11):2315-2321. doi: 10.1093/ibd/izy168. Review.

PMID:
29947781
33.

Third-Space Endoscopy.

Lichtenstein GR.

Gastroenterol Hepatol (N Y). 2018 Apr;14(4):203. No abstract available.

34.

Proton Pump Inhibitors.

Lichtenstein GR.

Gastroenterol Hepatol (N Y). 2018 Mar;14(3):135. No abstract available.

35.

Peficitinib, an Oral Janus Kinase Inhibitor, in Moderate-to-severe Ulcerative Colitis: Results From a Randomised, Phase 2 Study.

Sands BE, Sandborn WJ, Feagan BG, Lichtenstein GR, Zhang H, Strauss R, Szapary P, Johanns J, Panes J, Vermeire S, O'Brien CD, Yang Z, Bertelsen K, Marano C; Peficitinib-UC Study Group.

J Crohns Colitis. 2018 Nov 9;12(10):1158-1169. doi: 10.1093/ecco-jcc/jjy085.

PMID:
29917064
36.

The use of chromoendoscopy for surveillance of inflammatory bowel disease.

Lichtenstein GR, Picco MF, Solomon S, Bickston SJ.

VideoGIE. 2018 Feb 1;3(2):35-42. doi: 10.1016/j.vgie.2017.11.004. eCollection 2018 Feb. No abstract available.

37.

Correction: ACG Clinical Guideline: Management of Crohn's Disease in Adults.

Lichtenstein GR, Loftus EV Jr, Isaacs KL, Regueiro MD, Gerson LB, Sands BE.

Am J Gastroenterol. 2018 Jul;113(7):1101. doi: 10.1038/s41395-018-0120-x.

PMID:
29895986
38.

ACG Clinical Guideline: Management of Crohn's Disease in Adults.

Lichtenstein GR, Loftus EV, Isaacs KL, Regueiro MD, Gerson LB, Sands BE.

Am J Gastroenterol. 2018 Apr;113(4):481-517. doi: 10.1038/ajg.2018.27. Epub 2018 Mar 27. Erratum in: Am J Gastroenterol. 2018 Jul;113(7):1101.

PMID:
29610508
39.

Gluten-Free Diet.

Lichtenstein GR.

Gastroenterol Hepatol (N Y). 2018 Feb;14(2):67. No abstract available.

40.

Correlation between coronary artery calcification by non-cardiac CT and Framingham score in young patients.

Lichtenstein G, Perlman A, Shpitzen S, Durst R, Shaham D, Leitersdorf E, Szalat A.

PLoS One. 2018 Mar 28;13(3):e0195061. doi: 10.1371/journal.pone.0195061. eCollection 2018.

41.

Meeting Report: AGA Biosimilars Roundtable.

Howden CW, Lichtenstein GR.

Gastroenterology. 2018 Apr;154(5):e1-e5. doi: 10.1053/j.gastro.2018.03.002. Epub 2018 Mar 3. No abstract available.

PMID:
29510132
42.

Biosimilars in the Treatment of Inflammatory Bowel Disease: Supporting Evidence in 2017.

Scott FI, Lichtenstein GR.

Curr Treat Options Gastroenterol. 2018 Mar;16(1):147-164. doi: 10.1007/s11938-018-0177-z. Review.

PMID:
29492747
43.

Pain Management.

Lichtenstein GR.

Gastroenterol Hepatol (N Y). 2018 Jan;14(1):7. No abstract available.

44.

Infliximab for Crohn's Disease: More Than 13 Years of Real-world Experience.

Lichtenstein GR, Feagan BG, Cohen RD, Salzberg BA, Safdi M, Popp JW Jr, Langholff W, Sandborn WJ.

Inflamm Bowel Dis. 2018 Feb 15;24(3):490-501. doi: 10.1093/ibd/izx072.

45.

Overall and Comparative Risk of Herpes Zoster With Pharmacotherapy for Inflammatory Bowel Diseases: A Nationwide Cohort Study.

Khan N, Patel D, Trivedi C, Shah Y, Lichtenstein G, Lewis J, Yang YX.

Clin Gastroenterol Hepatol. 2018 Dec;16(12):1919-1927.e3. doi: 10.1016/j.cgh.2017.12.052. Epub 2018 Jan 5.

PMID:
29309905
46.

Indeterminate QuantiFERON-TB Gold Increases Likelihood of Inflammatory Bowel Disease Treatment Delay and Hospitalization.

Vajravelu RK, Osterman MT, Aberra FN, Roy JA, Lichtenstein GR, Mamtani R, Goldberg DS, Lewis JD, Scott FI.

Inflamm Bowel Dis. 2017 Dec 19;24(1):217-226. doi: 10.1093/ibd/izx019.

PMID:
29272482
47.

Postoperative Recurrence of Crohn's Disease.

Lichtenstein GR.

Gastroenterol Hepatol (N Y). 2017 Nov;13(11):642. No abstract available.

48.

Introduction to Biosimilar Use in Patients With Inflammatory Bowel Disease.

Lichtenstein GR.

Gastroenterol Hepatol (N Y). 2017 Oct;13(10):612-614. No abstract available.

49.

Fall Conferences.

Lichtenstein GR.

Gastroenterol Hepatol (N Y). 2017 Oct;13(10):574. No abstract available.

50.

The genetic architecture of photosynthesis and plant growth-related traits in tomato.

de Oliveira Silva FM, Lichtenstein G, Alseekh S, Rosado-Souza L, Conte M, Suguiyama VF, Lira BS, Fanourakis D, Usadel B, Bhering LL, DaMatta FM, Sulpice R, Araújo WL, Rossi M, de Setta N, Fernie AR, Carrari F, Nunes-Nesi A.

Plant Cell Environ. 2018 Feb;41(2):327-341. doi: 10.1111/pce.13084. Epub 2017 Nov 29.

PMID:
29044606

Supplemental Content

Loading ...
Support Center